Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neurofenix is a private neurorehabilitation company that provides technology-enabled virtual care programs for patients recovering from stroke and other neurological injuries. Its core offering combines therapist-led remote rehabilitation with proprietary sensor-based hardware and software, including the NeuroBall device and NeuroPlatform monitoring system, to support high-intensity therapy at home. The company focuses on improving access, engagement, and outcomes in neuro rehab through personalized programs, remote therapeutic monitoring, and gamified exercises. Neurofenix appears to be commercially active in the United States and originated in the United Kingdom, with Medicare-covered stroke therapy programs highlighted on its website. The business is positioned at the intersection of medtech, digital therapeutics, and virtual specialty care rather than as a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neurofenix.